Russell Investments Boosts McKesson Stock Holdings

Investment firm increases stake in pharmaceutical distributor by 0.5%

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Russell Investments Group Ltd. grew its stake in shares of McKesson Corporation (NYSE:MCK) by 0.5% during the third quarter, according to the company's recent 13F filing with the Securities & Exchange Commission. The fund now owns 321,175 shares of the company's stock, valued at approximately $247.7 million.

Why it matters

As one of the largest institutional investors in McKesson, Russell Investments' increased stake signals continued confidence in the pharmaceutical distribution company's performance and growth prospects. This news comes as McKesson navigates industry challenges like drug pricing pressures and supply chain disruptions.

The details

Russell Investments added 1,640 shares of McKesson during the third quarter, bringing its total holdings to 321,175 shares. This represents about 0.26% of the company's outstanding stock. McKesson is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and technology solutions to pharmacies, hospitals, and other providers.

  • Russell Investments filed its 13F report for the third quarter of 2026 on March 9, 2026.

The players

Russell Investments Group Ltd.

A global asset management firm that provides investment solutions to institutional and individual investors.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and technology solutions.

Got photos? Submit your photos here. ›

The takeaway

Russell Investments' increased stake in McKesson reflects ongoing institutional confidence in the company's ability to navigate industry challenges and maintain its position as a leading healthcare distribution and services provider.